Journal article icon

Journal article

The effect of obstructive sleep apnoea on hypoxic and inflammatory markers during CPAP withdrawal: Further evidence from three randomised control trials

Abstract:

Background and objective: Obstructive sleep apnoea (OSA) is associated with cardiovascular disease. Intermittent hypoxia, endothelial dysfunction and adipose tissue mediated inflammation have all been linked to cardiovascular disease in OSA. We have therefore explored the effect of OSA on relevant associated blood markers; adrenomedullin, endocan, endothelin-1, resistin and vascular endothelial growth factor.

Methods: Patients with OSA, established on and compliant with continuous positive airways pressure (CPAP) therapy for > 1 year were included from three randomised controlled trials, conducted at two centres. Patients were randomised to either continued therapeutic CPAP or sham CPAP (CPAP withdrawal) for two weeks. Blood markers were measured at baseline and at 14 days, and the treatment effect between sham CPAP and therapeutic CPAP was analysed.

Results: 109 patients were studied (therapeutic CPAP n=54, sham CPAP n=55). Sham CPAP was associated with a return of OSA (between-group difference in ODI +36.0/h, 95%CI +29.9 to +42.2, p<0.001). Sham CPAP was associated with a reduction in adrenomedullin levels at 14 days (-26.0 pg/ml, 95%CI 47.8 to -4.3, p=0.02), compared to therapeutic CPAP. Return of OSA was not associated with changes in endocan, endothelin-1, resistin or vascular endothelial growth factor.

Conclusions: Whilst CPAP withdrawal was associated with return of OSA, it was associated with an unexpected significant reduction in the vasodilator adrenomedullin and not with expected increases in hypoxia-induced markers, markers of endothelial function, or resistin. We propose that the vascular effects occurring in OSA may be brought about by other mechanisms, perhaps partly through a reduction in adrenomedullin.

Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1111/resp.12946

Authors

More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Sub department:
NDM Experimental Medicine
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Physiology Anatomy & Genetics
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Sub department:
NDM Experimental Medicine
Role:
Author


Publisher:
Wiley
Journal:
Respirology More from this journal
Volume:
22
Issue:
4
Pages:
793-799
Publication date:
2016-11-08
Acceptance date:
2016-09-08
DOI:
EISSN:
1440-1843
ISSN:
1323-7799


Pubs id:
pubs:643818
UUID:
uuid:4726a9a5-e9e3-46be-85b1-ea889726dad1
Local pid:
pubs:643818
Source identifiers:
643818
Deposit date:
2016-09-15
ARK identifier:

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP